Furthermore, the adoptive transfer of CD8+ T cell clones specific to EBV lytic antigen BMLF1 as well as latent antigen LMP2 has been shown to inhibit the development of B-cell lymphoma caused by EBV infection in humanized mice [50, 51]. This evidence concerns the gene CD8A and Epstein-Barr virus infection.